| INVESTIGAÇÃO DA CARDIOTOXICIDADE INDUZIDA POR ANTRACICLINAS E DOS MECANISMOS DE CARDIOPROTEÇÃO DO DEXRAZOXANO ATRAVÉS DA TÉCNICA DE COMETA EM MODELO DE IPS |
|
2024 |
| Eritropoiese ?in vitro?: desenvolvimento de protocolo de diferenciação eritrocitária a partir de células de pluripotência induzid |
|
2024 |
| CARACTERIZAÇÃO DAS CÉLULAS-TRONCO DE PLURIPOTÊNCIA INDUZIDA GERADAS A PARTIR DE PACIENTE COM SÍNDROME DE HUTCHINSON-GILFORD QUE TIVERAM MUTAÇÃO CORRIGIDA UTILIZANDO EDITOR DE BASE DE ADENINA |
|
2024 |
| RENOMICA: A ENFERMAGEM EM UM ACOMPANHAMENTO GENÉTICO DE CARDIOMIOPATIA DILATADA |
|
2024 |
| USO DE CARDIOMIÓCITOS DERIVADOS DE CÉLULAS-TRONCO HUMANAS DE PLURIPOTÊNCIA INDUZIDA DE PACIENTE COM CARDIOMIOPATIA PRKAG2 PARA ANÁLISE DA EXPRESSÃO RELATIVA DE GENES ASSOCIADOS À AMPK |
|
2024 |
| GENERATION OF THREE ISOGENIC INDUCED PLURIPOTENT STEM CELL LINES DERIVED FROM PATIENTS WITH HUTCHINSON-GILFORD PROGERIA SYNDROME USING ADENINE BASE EDITING |
|
2023 |
| SCN5A-H558R polymorphism has a synergistic contribution for a long QT syndrome phenotype |
|
2023 |
| CARACTERIZAÇÃO FENOTÍPICA E GENOTÍPICA DE CÉLULAS-TRONCO HUMANAS DE PLURIPOTÊNCIA INDUZIDA DE PACIENTE PORTADORA DE VARIANTE NO GENE PRKAG2 |
|
2022 |
| MODULAÇÃO DE PROPRIEDADES ELETROFISIOLÓGICAS CARDIOMIÓCITOS HUMANOS DERIVADOS DE CÉLULAS DE PLURIPOTÊNCIA INDUZIDA- IPS PELO TRATAMENTO COM SORO DE PACIENTES CHAGÁSICOS CRÔNICOS |
|
2022 |
| MEDICINA DE PRECISÃO: EDITANDO GENOMAS PARA FINS DIAGNÓSTICOS DE ARRITMIAS CARDÍACAS |
|
2022 |
| CÉLULAS-TRONCO DE PLURIPOTÊNCIA INDUZIDA GERADAS A PARTIR DE PACIENTE COM SÍNDROME DE HUTCHINSON-GILFORD COMO UMA FERRAMENTA PARA A OBTENÇÃO DE CARDIOMIÓCITOS |
|
2022 |
| CARACTERIZAÇÃO DAS CÉLULAS-TRONCO DE PLURIPOTÊNCIA INDUZIDA GERADAS A PARTIR DE PACIENTE COM SÍNDROME DE HUTCHINSON-GILFORD |
|
2022 |
| ESTABELECIMENTO DE MODELO DE CARDIOMIOPATIA INDUZIDA POR DOXORRUBICINA EM CAMUNDONGOS C57BL/6J |
|
2022 |
| MIMETIZANDO A CARDIOTOXICIDADE INDUZIDA POR ANTRACICLINAS UTILIZANDO CARDIOMIÓCITOS DERIVADOS DE CÉLULAS-TRONCO DE PLURIPOTÊNCIA INDUZIDA (IPSC) OBTIDAS DE PACIENTES TRATADOS COM ANTRACICLINAS |
|
2022 |
| INDUCED PLURIPOTENT STEM CELL-DERIVED CARDIOMYOCYTES FROM A PATIENT CARRYING AN UNPRECEDENTED VARIANT IN THE PRKAG2 GENE SHOW GLYCOGEN STORAGE AND ARE PROMISING TOOLS FOR THE IN VITRO STUDY OF THE METABOLIC CARDIOMYOPATHY |
|
2022 |
| GERAÇÃO DE CÉLULAS-TRONCO HUMANAS DE PLURIPOTÊNCIA INDUZIDA PARA O ESTUDO DA CARDIOMIOPATIA PRKAG2: UMA ABORDAGEM PARA A MODELAGEM IN VITRO DA SÍNDROME |
|
2022 |
| CARDIAC DIFFERENTIATION OF INDUCED PLURIPOTENT STEM CELLS DERIVED FROM PATIENTS WITH HUTCHINSON-GILFORD PROGERIA SYNDROME |
|
2021 |
| REVEALING HEART REGENERATION BY ESTABLISHMENT OF IN VIVO MODELS OF CARDIAC INJURY |
|
2021 |
| OBTAINING IN VITRO HUMAN-INDUCED PLURIPOTENT STEM CELLS-DERIVED CARDIOMYOCYTES: AN ALTERNATIVE TO PERSONALIZED MEDICINE IN CARDIO-ONCOLOGY |
|
2021 |
| STRATEGIES FOR HEPATOCYTE DIFFERENTIATION DERIVED FROM INDUCED PLURIPOTENT STEM CELLS USING SPHEROIDS |
|
2021 |
| 26 DEVELOPMENT OF AN IN VITRO STUDY MODEL OF PRKAG2 CARDIOMYOPATHY USING HUMAN INDUCED PLURIPOTENT STEM CELLS |
|
2021 |
| TRANSCRIPTOME ANALYSIS OF HEPATOCYTES DERIVED FROM HUMAN INDUCED PLURIPOTENT STEM CELLS |
|
2021 |
| EFFECTS OF CHAGASIC PATIENT'S SERA ON HUMAN INDUCED PLURIPOTENT STEM CELL-DERIVED CARDIOMYOCYTES |
|
2021 |
| EFFECTS OF DOXORUBICIN ON HUMAN INDUCED PLURIPOTENT STEM CELL-DERIVED CARDIOMYOCYTES OBTAINED FROM PATIENTS SENSITIVE AND RESISTANT TO ANTHRACYCLINE-INDUCED CARDIOTOXICITY |
|
2021 |
| 30 EARLY EFFECTS OF EXTRACELLULAR VESICLES SECRETED BY ADIPOSE TISSUE MESENCHYMAL CELLS IN RENAL ISCHEMIA FOLLOWED BY REPERFUSION: MECHANISMS RELY IN THE RESTORATION OF THE REDOX TISSULAR ENVIRONMENT |
|
2021 |
| MODELING LONG QT SYNDROME IN IPS-DERIVED CARDIOMYOCYTES FROM A PATIENT HARBORING THE KCNQ1- I588T MUTATION |
|
2021 |
| Effects of Chagasic patients' sera on human cardiomyocytes derived from iPS |
|
2021 |
| Infecção de megacarioblastos humanos em diferenciação pelo vírus da febre amarela |
|
2018 |
| As células-tronco podem ser utilizadas como tratamento para cardiomiopatia induzida por doxorrubicina? |
|
2018 |
| Avanços na medicina personalizada na SqTL1 utilizando cardiomiócitos paciente-específicos |
|
2018 |
| Investigating Long QT Syndrome type 1 by in vitro generation of human patient-specific cardiomyocytes |
|
2018 |
| Challenges to modeling JLNS using patient-specific cardiomyocytes derived from induced pluripotent stem cells |
|
2018 |
| Patient-specific iPSC-derived cardiomyocytes as a model of type 1 Long QT Syndrome |
|
2018 |
| Action potential variability in human pluripotent stem-derived cardiomyocytes obtained from healthy donors |
|
2018 |
| ABTCEL -X Congress |
|
2018 |
| Modelling a novel KCNQ1 gene variant associated with Type I Long-QT Syndrome |
|
2017 |
| Uma nova alternativa para medicina personalizada: geração in vitro de cardiomiócitos paciente-específicos a partir de células-tronco de pluripotência induzida |
|
2017 |
| Modeling premature cardiac aging by induced pluripotent stem cell from a patient with Hutchinson-Gilford progeria syndrome (HGPS) |
|
2017 |
| Genomic Integrity in Induced Pluripotent Stem Cells |
|
2017 |
| Embryonic stem cell-derived cardiomyocytes improve cardiac function in a mouse model of doxorubicin-induced cardiomyopathy |
|
2017 |
| Investigação dos Mecanismos Moleculares da Síndrome do QT Longo do tipo 2 utilizando cardiomiócitos derivados de iPSC |
|
2017 |
| Medicina Personalizada na SQTL1: geração in vitro de cardiomiócitos paciente-específicos |
|
2017 |
| Bone marrow mesenchymal stem cell therapy in a canine model of chagasic cardiomyopathy |
|
2017 |
| Investigating Molecular mechanisms of Type 2 Long QT Syndrome with iPSC-derived cardiomyocytes |
|
2017 |
| Modelling premature cardiac aging by induced pluripotent stem cell from a patient with hutchinson-Gliford progeria syndrome |
|
2017 |
| Avaliação do potencial terapêutico das células estromais mesenquimais derivadas de medula óssea em modelo de cardiomiopatia chagásica canina |
|
2017 |
| Investigação das possíveis alterações causadas pela infecção pelo vírus da febre amarela na diferenciação de megacarioblastos humanos |
|
2017 |
| Does yellow fever virus induce alterations in differentiation process of megakaryoblasts? |
|
2017 |
| Investigation of possible alterations in megakaryoblasts differentiation caused by the infection of yellow fever virus |
|
2017 |
| Infection of Megacayoblasts under differentiation by yellow fever virus |
|
2017 |
| Avaliação da Instabilidade Genética de Células-tronco Pluripotentes Induzidas |
|
2016 |
| Modelling Type 2 long QT syndrome using iPSC-derived cardiomyocytes |
|
2016 |
| Morphologic and Functional Evaluation of Myocardial Infarction in Wistar Rats: a Comparative Study Between Females and Males |
|
2015 |
| Improvement of Cardiac Function by Embryonic Stem Cell Derived Cardiomyocytes in Doxorubicin Induced Cardiomyopathy Model |
|
2015 |
| Embryonic stem cell-derived cardiomyocytes increase viable myocardium but do not improve function in a mouse model of chagasic cardiomyopathy |
|
2015 |
| Avaliação morfo-funcional do infarto do miocárdio em ratos Wistar: um estudo comparativo entre fêmeas e machos |
|
2015 |
| Generation and Cardiac Differentiation of Feedere Free iPSC |
|
2014 |
| Cardiomyocytes Derived from Mouse Embryonic Stem Cells Improve Cardiac Function in Doxorubicin-Induced Cardiomyopathy |
|
2014 |
| Characterization of Cardiac Progenitor Cells and Evaluation of their Therapeutical Potential in a Murine Model of Healed Myocardial Infarction |
|
2014 |
| Uma nova perspectiva para o estudo da Síndrome do QT longo: geração de células-tronco pluripotentes induzidas pacientes-específicas |
|
2014 |
| Human cardiac stem cell therapy in immunossuppressed rats with myocardial infarction |
|
2012 |
| Temporal expression of c-kit in the heart: difficulties and chalenges in cell therapy |
|
2012 |
| Isolation, culture and characterization of cardiospheres-derived cells from CD1 mice |
|
2012 |
| Reprogramming of oxidative stress responses in human induced pluripotent stem cells derived from menstrual blood |
|
2012 |
| Direct reprogramming of fibroblasts into cardiomyocytes by ectopic gene expression of GATA-4, MEF2c and TBX5 |
|
2012 |
| Reprogramming to a Pluripotent State Modifies Menstrual Blood-Derived Mesenchymal Stem Cell Resistance to Oxidative Stress |
|
2012 |
| MESENCHYMAL STEM CELLS FROM MENSTRUAL BLOOD ARE MORE RESISTANT TO OXIDATIVE STRESS THAN PLURIPOTENT STEM CELLS. |
|
2012 |
| Development of chagasic cardiomyopathy model in chimeric mice |
|
2011 |
| Cardiomyogenic potential of cardiosphere-derived cells |
|
2011 |
| Isolation of clonogenic c-kit positive cells from human heart |
|
2011 |
| Mesenchymal cells obtained from human amniotic fluid: characterization and evaluating their potential to differentiate into cardiomyocytes |
|
2011 |
| Cardiac differentiation of human umbilical cord-deived stromal cells |
|
2011 |
| Eletrophysiological characterization of umbilical cord-derived stromal cells |
|
2011 |
| Transplantation of human placenta-derived mesenchymal stromal cells improves cardiac performance of immunocompetent mice submitted to myocardial infarction |
|
2011 |
| Human menstrual blood as a source of stem cells resistant to oxidative stress |
|
2011 |
| Menstrual blood-derived stem cells are not impaired by oral-contraceptives |
|
2011 |
| Characterization of freshly isolated non-myocyte cell populations from mouse hearts |
|
2011 |
| Isolation and characterization of cardiosphere derived cell from human heart |
|
2011 |
| Bone marrow transplantation: what is the best delivery site for engrafment in mice? |
|
2011 |
| Adipose-Derived Stromal Cell Therapy Stabilizes Cardiac Function and Improves Border Zone Remodeling After Coronary Occlusion in Rats |
|
2011 |
| Characterization of cells from human amniotic fluid and evaluating their potential to differentiate into cardiomyocytes |
|
2011 |
| HUMAN MENSTRUAL BLOOD-DERIVED MESENCHYMAL CELLS: CHARACTERIZATION AND EVIDENCE FOR ENHANCED RESISTANCE AGAINST OXIDATIVE STRESS |
|
2011 |
| PRELIMINARY STUDY OF MOUSE EMBRYONIC STEM CELL TRANSPLANTATION IN MICE EXPERIMENTALLY INFECTED WITH T. cruzi. |
|
2011 |
| TRANSPLANTATION AND BIODISTRIBUTION OF HUMAN PLACENTA-DERIVED MESENCHYMAL STROMAL CELLS IN IMMUNOCOMPETENT MICE SUBMITTED TO MYOCARDIAL INFARCTION. |
|
2011 |
| Transplantation of placenta-derived mesenchymal stem cells in immunocompetent mice submitted to myocardial infarction |
|
2011 |
| The development of a chagasic cardiomyopathy model in chimeric mice |
|
2011 |
| Cardiomyocyte differentiation of human amniotic fluid-derived mesenchymal stem cells |
|
2010 |
| Human Menstrual Blood derived mesenchymal cells are an alternative feeder-layer for human embryonic stem cells |
|
2010 |
| Effects of Trypanosoma cruzi infection in human cardiac progenitor cells |
|
2010 |
| A comparative study of human fetal extra-embryonic mesenchymal stem cells |
|
2010 |
| Transplantation of placenta-derived mesenchymal stem cells in immunocompetent mice submitted to myocardial infarction |
|
2010 |
| Human hair follicle feeder-layers support undifferentiated growth of human embryonic stem cells |
|
2010 |
| Biodistribuição de células mononucleares de medula óssea marcadas com 99mTecnécio após injeção intra-arterial ou intravenosa em pacientes com AVC isquêmico crônico |
|
2010 |
| Cardiosphere-derived cells have a mesenchymal phenotype and express contractile molecules when co-cultured with neonatal cardiomyocytes |
|
2010 |
| Cardiosphere-derived cells: new perspective in the cardiac cell therapy |
|
2010 |
| Stem Cells amniotic fluid-derived might be considered an alternative source of stem cells for cardiac cell therapy |
|
2010 |
| Immunophenotyping and differentiation of adherent fraction of cells isolated from human cardiac biopsies |
|
2010 |
| Isolation and characterization of human umbilical cord stromal cells |
|
2010 |
| Human Menstrual Blood and hair follicle derived mesenchymal cells are alternative feeder-layer for mouse and human embryonic stem cells |
|
2010 |
| Mouse Embryonic Stem Cell Transplantation in Mice Experimentally Infected with T. cruzi : Preliminary Results. |
|
2010 |
| Infection with Trypanosoma cruzi does not promote apoptosis in human cardiac progenitor cells |
|
2010 |
| Placenta-derived mesenchymal stromal cells in myocardial infarction therapy: preliminary results. |
|
2010 |
| Characterization of human menstrual blood-derived mesenchymal cells and detection by bioluminescence imaging in vivo. |
|
2010 |
| Avaliação da distribuição de células mononucleares de medula óssea marcadas com 99mTecnécio após injeção intra-arterial ou intravenosa em pacientes com AVC isquêmico crônico |
|
2010 |
| Investigação do potencial de diferenciação in vitro das células-tronco derivadas do líquido amniótico humano em cardiomiócitos. |
|
2010 |
| THE AMNIOTIC FLUID AS A SOURCE OF CELLS FOR CELL THERAPY |
|
2010 |
| A comparative study of human fetal extra-embryonic mesenchymal stem cells |
|
2010 |
| Morpho-functional characterization of bone marrow cells isolated from patients with chronic diseases |
|
2009 |
| Isolation and characterization of human umbilical cord stromal cells |
|
2009 |
| Expression of cardiac-specific genes by multipotent human amniotic fluid-derived stem cells: preliminary results |
|
2009 |
| Analysis of cell populations obtained from C57/BL6-Tg pCX (a-act)EGFP Transgenic mice adipose tissue |
|
2009 |
| Isolamento, caracterização e diferenciação das células humanas derivadas do sangue menstrual |
|
2009 |
| Células derivadas do líquido amniótico humano: nova perspectiva de célula-tronco |
|
2009 |
| Characterization of cardiac progenitor cells from human adult myocardium |
|
2009 |
| Characterization of placenta derived stem cells |
|
2009 |
| Isolation and characterization of bone marrow-derived mesenchymal stem cells from alpha actin cardiac-EGFP transgenic mice |
|
2009 |
| Isolation, expansion and characterization of cardiac stem cells from adult murine heart |
|
2009 |
| Menstrual blood-derived cells: new progenitor cell source for stem cell-based therapies |
|
2009 |
| Morphologic and Phenotypic Characterization of Cell Populations Obtained from Outbred Wistar Rat Adipose Tissue Derived Cells |
|
2009 |
| In vitro study of human bone marrow mononuclear and mesenchymal cells derived from stroke patients |
|
2008 |
| Term placenta as a new source of multipotent mesenchymal stromal cells |
|
2008 |
| Human amniotic fluid derived cells: new perspective stem cells |
|
2008 |
| Células mesenquimais derivadas da placa coriônica: um estudo sobre isolamento, caracterização e diferenciação |
|
2008 |
| Isolation and characterization of amniotic membrane mesenchymal cells |
|
2008 |
| Isolamento, caracterização, diferenciação e cultivo das células derivadas do fluido amniotico humano |
|
2008 |
| Células derivadas do fluido amniótico humano: uma nova fonte de célula-tronco mesenquimal? |
|
2008 |
| Expression of muscle markers in bone marrow mesenchymal stem cells |
|
2007 |
| Expression of muscle markers in bone marrow mesenchymal stem cells. |
|
2007 |
| Isolamento, caracterização e cultivo de células de medula óssea humana |
|
2007 |
| Autologous bone marrow mononuclear cell transplantationin patients with schemic stroke |
|
2007 |
